SAUDI TOURISM CAPTIVATES AUDIENCES AND STRENGTHENS GLOBAL PARTNERSHIPS AT WTM 2025

— Saudi Tourism Authority signed nineMoUs/agreements, facilitated twenty-seven MoUs/agreements between Saudi partners and the global tourism sector, and held more than 500 strategic meetings with the travel and tourism trade at WTM 2025. — Building on the achievement of welcoming almost 116 million visitors in 2024 and up to 60 million in the first half […]

Hisense Accelerates ESG Strategy with AI-Driven Sustainability Milestones

Hisense, a leading brand in global consumer electronics and home appliances, today announced progress in its Environmental, Social and Governance (ESG) journey, advancing the strategic upgrade outlined in its 2024 ESG Report. Centered on “technology powered by AI,”Hisense is accelerating responsible innovation across manufacturing, social impact, and governance through a dual-track approach of “intelligence +

SY Holdings Invited to Attend 2025 Hong Kong FinTech Week, Leveraging AI to Boost the Development and Global Expansion of SMEs

From November 3 to 4, 2025, “Hong Kong FinTech Week x StartmeupHK Festival 2025” (hereinafter referred to as “Hong Kong FinTech Week”) was grandly held at the Hong Kong Convention and Exhibition Centre. The event is organized by the Hong Kong Financial Services and the Treasury Bureau, the Hong Kong Commerce and Economic Development Bureau,

ATFX Group Celebrates Awards and Market Leadership at iFX EXPO Asia 2025

ATFX Group, comprising ATFX and ATFX Connect, highlighted their leadership in both retail and institutional trading solutions at iFX EXPO Asia 2025, held from 26-28 October at AsiaWorld-Expo. The event emphasized the Group's strong presence across the Asia-Pacific region and its commitment to innovation and client-focused growth. At the event, ATFX received the Best MT4

Levi & Korsinsky Investigates Possible Securities Fraud by Molina Healthcare, Inc. (MOH)

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE:MOH) concerning possible violations of federal securities laws. On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its

Investors in Savara Inc. (SVRA): Protect Your Rights – Contact Levi & Korsinsky Before November 7, 2025

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=176014&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Shareholders of aTyr Pharma, Inc. (ATYR): Protect Your Rights Before December 8, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=176020&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

BIO-key Secures Significant Identity and Biometric Security Deployment with a Major Middle East Defense Sector Organisation

BIO-key Secures Significant Identity and Biometric Security Deployment with a Major Middle East Defense Sector Organisation GlobeNewswire November 07, 2025 HOLMDEL, N.J. and RIYADH, Saudi Arabia, Nov. 07, 2025 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, has secured a significant new

Viral Vector & Plasmid DNA Manufacturing Market to Surpass USD 27.71 Billion by 2034

Ottawa, Nov. 07, 2025 (GLOBE NEWSWIRE) — The global viral vector & plasmid DNA manufacturing market size is calculated at USD 6.52 billion in 2024, grows to USD 7.54 billion in 2025, and is projected to reach around USD 27.71 billion by 2034, growing at a CAGR of 15.57% during the forecast period 2025 to

Viral Vector & Plasmid DNA Manufacturing Market to Surpass USD 27.71 Billion by 2034

Viral Vector & Plasmid DNA Manufacturing Market to Surpass USD 27.71 Billion by 2034 According to Nova One Advisor, the global viral vector & plasmid DNA manufacturing size is calculated at USD 7.54 billion in 2025 and is expected to surpass around USD 27.71 billion by 2034, growing at a compound annual growth rate (CAGR)

Scroll to Top